跳至主要内容
临床试验/EUCTR2007-003009-28-DK
EUCTR2007-003009-28-DK进行中(未招募)不适用

The effect of TNF alpha inhibition on the early clinical course of Polymyalgia Rheumatica (pilot study). - N/A

Department of Rheumatology0 个研究点目标入组 40 人开始时间: 2007年6月27日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with newly diagnosed polymyalgia rheumatica.
  • Patients must:
  • - Suffer from pain and stiffness in proximal limb muscles.
  • - Be above 50 years of age.
  • - Have a ESR of more than 40 mm per hr.
  • - Have elevated levels of CRP.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Other inflammatory diseases than polymyalgia rheumatica, including sings of giant cell arteritis, eg. headache, masseter muscle claudication, and visual disturbances.
  • Malignant or neuromuscular diseases, infections with systemic impact (especially tuberculosis and hepatitis), severe heart disease (NYHA class 3 and 4).

研究者

相似试验